ACC 2019: Duration Of Diabetes And Cardiorenal Efficacy Of Liraglutide And Semaglutide - Prof Subodh Verma
Prof Subodh Verma (University of Toronto, Toronto, CA) discusses his poster presented at the ACC 2019 entitled duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide - a post hoc analysis of the LEADER and SUSTAIN-6 Clinical Trials.
Filmed on site at ACC 2019 by Radcliffe Cardiology
Videography: Josh Birch
Interviewer: Liam O'Neill
This video is aimed at:
Prof Subodh Verma
University of Toronto, Toronto, CA.
There is no accreditation associated to viewing this content.